Quick Answer
Acumen Pharmaceuticals, Inc. reported Stockholders Equity of $70.43 million for fiscal year 2025.
Acumen Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $70.43M | -61.3% |
| 2024 | $181.82M | -31.9% |
| 2023 | $266.97M | +41.4% |
| 2022 | $188.78M | -16.2% |
| 2021 | $225.18M | +1311.2% |
| 2020 | -$18.59M | -62.8% |
| 2019 | -$11.42M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $93.17M | -57.1% | -20.4% |
| June 30, 2025 | $117.08M | -52.0% | -24.7% |
| March 31, 2025 | $155.52M | -40.6% | -14.5% |
| December 31, 2024 | $181.82M | -31.9% | -16.3% |
| September 30, 2024 | $217.20M | -22.5% | -11.0% |
| June 30, 2024 | $243.95M | +44.5% | -6.9% |
| March 31, 2024 | $262.03M | +46.3% | -1.8% |
| December 31, 2023 | $266.97M | +41.4% | -4.7% |
- Acumen Pharmaceuticals, Inc. showed a decrease of -61.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Acumen Pharmaceuticals, Inc.’s stockholders equity has grown by 716.7% (from -$11.42 million to $70.43 million).
- The most recent figure is from Acumen Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: